Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
A new hydrogel for treatment and recovery of muscle injuries

A new hydrogel for treatment and recovery of muscle injuries

Chemical cocktail shows promise for producing muscle stem cells

Chemical cocktail shows promise for producing muscle stem cells

FDA approval provides targeted treatment option for patients with rare DMD mutation

FDA approval provides targeted treatment option for patients with rare DMD mutation

Canadian Neuromuscular Disease Registry increases patient access to research, clinical trials

Canadian Neuromuscular Disease Registry increases patient access to research, clinical trials

Study provides new insights into the molecular underpinnings of Duchenne muscular dystrophy

Study provides new insights into the molecular underpinnings of Duchenne muscular dystrophy

Study unlocks some muscle cell secrets

Study unlocks some muscle cell secrets

Genethon to start international clinical trial for treatment of Duchenne muscular dystrophy

Genethon to start international clinical trial for treatment of Duchenne muscular dystrophy

New method could help determine the most appropriate treatment for HIV patients

New method could help determine the most appropriate treatment for HIV patients

CRISPR/Cas9 system is highly effective in treating metastatic cancers

CRISPR/Cas9 system is highly effective in treating metastatic cancers

Genetic mutation may accelerate heart function decline in DMD patients

Genetic mutation may accelerate heart function decline in DMD patients

New drug offers hope for young boys with Duchenne muscular dystrophy

New drug offers hope for young boys with Duchenne muscular dystrophy

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Yale researchers identify possible treatment for Duchenne muscular dystrophy

Yale researchers identify possible treatment for Duchenne muscular dystrophy

Researchers find link between dystrophic muscles and lymphatic system in mice with Duchenne disease

Researchers find link between dystrophic muscles and lymphatic system in mice with Duchenne disease

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

FDA approves new treatment option for patients with rare Duchenne muscular dystrophy mutation

Heart cell treatment can benefit patients, shows study

Heart cell treatment can benefit patients, shows study

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

New editorial published following adverse events of gene therapy clinical trial

New editorial published following adverse events of gene therapy clinical trial

Micro-dystrophin gene therapy can improve outcomes in children with Duchenne muscular dystrophy

Micro-dystrophin gene therapy can improve outcomes in children with Duchenne muscular dystrophy